Early research (Phase 1)Study completedNCT02315066What this trial is testingStudy Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566Who this might be right forNeoplasms Pfizer 174
Post-approval studies (Phase 4)Study completedNCT02982954What this trial is testingEvaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell CancerWho this might be right forRenal Cell Carcinoma Bristol-Myers Squibb 211
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Not applicableStudy completedNCT07024680What this trial is testingReal World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCCWho this might be right forPapillary Renal Cell Carcinoma AstraZeneca 48
Not applicableWithdrawnNCT00499291What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWho this might be right forCancer Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012371What this trial is testingLenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell CancerWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06896552What this trial is testingSingle-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.Who this might be right forCancerImmunotherapyKetogenic Diet Rabin Medical Center 60
Early research (Phase 1)Ended earlyNCT04152018What this trial is testingStudy of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.Who this might be right forSquamous Cell Carcinoma of the Head and NeckRenal Cell CarcinomaOvarian Cancer+8 more Pfizer 85
Early research (Phase 1)Active Not RecruitingNCT05239143What this trial is testingP-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsWho this might be right forBreast CancerOvarian CancerNon Small Cell Lung Cancer+6 more Poseida Therapeutics, Inc. 180
Testing effectiveness (Phase 2)Ended earlyNCT00975806What this trial is testingStudy of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Celgene 16
Testing effectiveness (Phase 2)UnknownNCT01577784What this trial is testingPazopanib in Second-line Therapy in Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Associació per a la Recerca Oncologica, Spain 27
Testing effectiveness (Phase 2)Looking for participantsNCT07510334What this trial is testingVSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more Mayo Clinic 18
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03635892What this trial is testingNivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced or Metastatic Non-clear Cell Renal Cell CarcinomaUnclassified Renal Cell CarcinomaPapillary Renal Cell Carcinoma+4 more Memorial Sloan Kettering Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT00410124What this trial is testingRAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or SunitinibWho this might be right forMetastatic Renal Cell Carcinoma Novartis Pharmaceuticals 416
Large-scale testing (Phase 3)Ended earlyNCT04338269What this trial is testingAtezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor TreatmentWho this might be right forCarcinoma, Renal Cell Hoffmann-La Roche 522
Large-scale testing (Phase 3)Study completedNCT03260894What this trial is testingPembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)Who this might be right forRenal Cell Carcinoma (RCC) Incyte Corporation 129
Early research (Phase 1)Active Not RecruitingNCT03845166What this trial is testingXL092 as Single-Agent and Combination Therapy in Subjects With Solid TumorsWho this might be right forNeoplasm MalignantRenal Cell CarcinomaHormone Receptor Positive Breast Carcinoma+2 more Exelixis 325
Early research (Phase 1)Study completedNCT04148937What this trial is testingThe CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 52
Testing effectiveness (Phase 2)Looking for participantsNCT05706129What this trial is testingAssess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid TumorsWho this might be right forClear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more Lumara Bio Oncologics GmbH 270